MTOR Cross-Talk in Cancer and Potential for Combination Therapy.
Ontology highlight
ABSTRACT: The mammalian Target of Rapamycin (mTOR) pathway plays an essential role in sensing and integrating a variety of exogenous cues to regulate cellular growth and metabolism, in both physiological and pathological conditions. mTOR functions through two functionally and structurally distinct multi-component complexes, mTORC1 and mTORC2, which interact with each other and with several elements of other signaling pathways. In the past few years, many new insights into mTOR function and regulation have been gained and extensive genetic and pharmacological studies in mice have enhanced our understanding of how mTOR dysfunction contributes to several diseases, including cancer. Single-agent mTOR targeting, mostly using rapalogs, has so far met limited clinical success; however, due to the extensive
SUBMITTER: Conciatori F
PROVIDER: S-EPMC5789373 | biostudies-literature | 2018 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA